Matches in Wikidata for { <http://www.wikidata.org/entity/Q71699065> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q71699065 description "artículu científicu espublizáu en xunetu de 1996" @default.
- Q71699065 description "im Juli 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71699065 description "scientific article published on 01 July 1996" @default.
- Q71699065 description "wetenschappelijk artikel" @default.
- Q71699065 description "наукова стаття, опублікована в липні 1996" @default.
- Q71699065 name "Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients" @default.
- Q71699065 name "Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients" @default.
- Q71699065 type Item @default.
- Q71699065 label "Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients" @default.
- Q71699065 label "Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients" @default.
- Q71699065 prefLabel "Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients" @default.
- Q71699065 prefLabel "Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients" @default.
- Q71699065 P1433 Q71699065-2E76581D-1710-4D02-9432-1A008F4CE140 @default.
- Q71699065 P1476 Q71699065-17D24332-275B-480C-80FF-5E4106DCAFC7 @default.
- Q71699065 P2093 Q71699065-04908924-D342-4E7D-9DFE-922E84B91E8E @default.
- Q71699065 P2093 Q71699065-13C31033-F61B-49A7-B168-B1AA7F3E5951 @default.
- Q71699065 P2093 Q71699065-228E05F3-4358-46FB-AB3F-F1426D8410F7 @default.
- Q71699065 P2093 Q71699065-280072CE-8BB5-4741-8310-3EAFC1310C34 @default.
- Q71699065 P2093 Q71699065-3CB9DDAA-049D-4F07-B3FE-6A9FE05B0209 @default.
- Q71699065 P2093 Q71699065-52F5398F-E59F-446C-A39B-0E28B3B76A46 @default.
- Q71699065 P2093 Q71699065-6243BAC3-3100-433C-8FD6-5363B07A3449 @default.
- Q71699065 P2093 Q71699065-7334EE9A-45B2-4EFA-912B-A5DC8ABA0DDD @default.
- Q71699065 P2093 Q71699065-80F43FC7-7D02-403F-861D-84C5AF4E0753 @default.
- Q71699065 P2093 Q71699065-8300406A-4473-492E-BF2A-32ADA9C421BC @default.
- Q71699065 P2093 Q71699065-887B6871-6106-4EFD-B1F0-6725ED38A572 @default.
- Q71699065 P2093 Q71699065-903BA712-6A41-4AAA-9D75-FFF3C6301A6C @default.
- Q71699065 P2093 Q71699065-AAA78B22-C9F2-4A28-A24F-C24CE63D2955 @default.
- Q71699065 P2093 Q71699065-AAC89F41-A952-452A-A235-FCC09E248463 @default.
- Q71699065 P2093 Q71699065-F3BE78FF-396C-4380-9649-7B28EEEA5480 @default.
- Q71699065 P2093 Q71699065-F68A29E3-14B1-4D9E-9A81-336E28D0E174 @default.
- Q71699065 P2093 Q71699065-F76FEB8B-C51A-4151-99A0-DC8E749AD425 @default.
- Q71699065 P304 Q71699065-F7A7515F-3070-45D6-9906-CAC88EE34389 @default.
- Q71699065 P31 Q71699065-71FB83BD-2FD3-4F87-A805-10F4FCAAA329 @default.
- Q71699065 P433 Q71699065-CB243C82-9FBF-4DB1-B62F-F058C73209F1 @default.
- Q71699065 P478 Q71699065-3E8C4EDC-9EB9-4638-9911-C24F83F86BE6 @default.
- Q71699065 P50 Q71699065-CE9D31E3-94E5-41D4-B43E-4DDE93EB5110 @default.
- Q71699065 P577 Q71699065-D2BFFC97-0D30-42C5-ADD0-B0E01C5E5547 @default.
- Q71699065 P698 Q71699065-973AF686-C287-4AF3-A1B9-E74DF374ED38 @default.
- Q71699065 P921 Q71699065-E20AAAC7-805F-4EEE-AF75-859573DD222C @default.
- Q71699065 P698 8877723 @default.
- Q71699065 P1433 Q27714027 @default.
- Q71699065 P1476 "Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients" @default.
- Q71699065 P2093 "Alvord WG" @default.
- Q71699065 P2093 "Creekmore SP" @default.
- Q71699065 P2093 "Curti BD" @default.
- Q71699065 P2093 "Fenton RG" @default.
- Q71699065 P2093 "Gause BL" @default.
- Q71699065 P2093 "Hawk C" @default.
- Q71699065 P2093 "Holmlund JT" @default.
- Q71699065 P2093 "Janik JE" @default.
- Q71699065 P2093 "Kopp WC" @default.
- Q71699065 P2093 "Kremers P" @default.
- Q71699065 P2093 "Miller L" @default.
- Q71699065 P2093 "Ochoa AC" @default.
- Q71699065 P2093 "Powers G" @default.
- Q71699065 P2093 "Sharfman WH" @default.
- Q71699065 P2093 "Smith JW 2nd" @default.
- Q71699065 P2093 "Sznol M" @default.
- Q71699065 P2093 "Urba WJ" @default.
- Q71699065 P304 "296-308" @default.
- Q71699065 P31 Q13442814 @default.
- Q71699065 P433 "4" @default.
- Q71699065 P478 "19" @default.
- Q71699065 P50 Q12100062 @default.
- Q71699065 P577 "1996-07-01T00:00:00Z" @default.
- Q71699065 P698 "8877723" @default.
- Q71699065 P921 Q5452194 @default.